Latest Lapatinib Stories
Ariad Pharmaceuticals has initiated a Phase II clinical trial to examine the efficacy and safety of oral deforolimus, its investigational mTOR inhibitor, in patients with advanced breast cancer.
The medical advisory panel to the UK National Health Service has recommended that GlaxoSmithKline's Tyverb should not be used on the NHS to treat advanced metastatic breast cancer on the grounds that it is not effective enough to justify its cost.
The National Institute of Health and Clinical Excellence has advised against the use of GlaxoSmithKline's oral cancer drug Tyverb in the UK's National Health Service, reported the Financial Times.
Cytokinetics, Incorporated (NASDAQ: CYTK) announced today the results of a Phase Ib clinical trial designed to evaluate ispinesib in combination with capecitabine, an oral chemotherapy agent commonly used in the treatment of breast cancer.
By Claire Harrison Dr Seamus McAleer has been involved in trials of a new drug called Lapatinib at Belfast City Hospital which has offered women suffering a type of advanced breast cancer hope by slowing the disease.
A CANCER drug that Jane Tomlinson's husband said should be made widely available has been launched in the UK. Lapatinib can prolong the lives of women suffering a type of advanced breast cancer by stopping the disease from growing.
KIM Robson pounded the streets of Leeds in Jane Tomlinson's Run for All last year and will line up with thousands of others against for the event next week.
NEW drug lapatinib is described as a "stealth fighter" against breast cancer. It is not a cure but temporarily stops progression of the disease for women with advanced cases of breast cancer who test positive for the protein HER2.
By Lisa Richwine ATLANTA (Reuters) - An experimental drug added to chemotherapy slowed aggressive, late-stage breast cancers that resumed growing despite standard treatment with the drug Herceptin, U.S. researchers said on Saturday.
ATLANTA (Reuters) - GlaxoSmithKline's experimental pill Tykerb helped some patients with advanced kidney cancer live longer, French researchers reported on Saturday.